Navigation Links
Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
Date:4/23/2009

MADISON, N.J., April 23 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) announced today that it will fully redeem all of its outstanding $2 Convertible Preferred Stock, par value $2.50 per share (the "Convertible Preferred Stock") effective on July 15, 2009 (the "Redemption Date"). As of April 22, 2009, there were 8,896 shares of Convertible Preferred Stock outstanding.

The redemption price for each share of Convertible Preferred Stock is $60.08, which includes an amount equal to all accrued but unpaid dividends up to, and including, the Redemption Date. Wyeth announced earlier today that a dividend of fifty cents ($.50) per share on the outstanding shares of Convertible Preferred Stock was declared, payable on July 1, 2009 to stockholders of record at the close of business on June 12, 2009. The redemption of the Convertible Preferred Stock will not impact today's dividend declaration as the dividend payment date will occur prior to the Redemption Date. The redemption agent is BNY Mellon Shareowner Services, Corporate Actions Division, P.O. Box 3301, South Hackensack, New Jersey 07606.

Prior to the close of business on the Redemption Date, holders may elect to convert all, or a portion of, their Convertible Preferred Stock into Wyeth common stock, par value $0.33 1/3 per share (the "Common Stock"), by surrendering their shares of Convertible Preferred Stock by mail to the address previously stated or to the office of Wyeth's transfer agent, BNY Mellon Shareowner Services, located at 480 Washington Boulevard, Attn: Corporate Actions Division, 27th Floor, Jersey City, New Jersey 07310. Each share of Convertible Preferred Stock is convertible into 36 shares of Common Stock. On April 22, 2009, the closing price of Wyeth's Common Stock on the New York Stock Exchange was $41.92 per share. If the merger between Wyeth and Pfizer Inc. ("P
'/>"/>

SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Wyeth Declares Common and Preferred Stock Dividends
2. Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings
3. Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference
4. Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
5. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
6. Wyeth Declares Preferred Stock Dividend
7. Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
8. Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
9. Wyeth Announces Increase in Common Stock Dividend
10. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
11. Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Quincy Bioscience, ... and development of calcium-binding proteins to support healthy ... safety assessment study of apoaequorin in ... published for the British Industrial Biological Research Association. ... to investigate potential adverse effects, if any, of ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
(Date:5/23/2013)... 23, 2013 PuraMed BioScience ® , ... of over-the-counter (OTC) medicinal and healthcare products, announced ... the company based on low market capitalization valuation. ... All Natural Product to Treat Migraine Headaches ... Prescription Competitor , Currently Available Nationwide at ...
(Date:5/23/2013)... May 23, 2013 VG Energy, an ... with DAK Renewable Research to conduct field trials ... VG Energy is a majority owned subsidiary of ... VG Energy,s exclusively licensed compound LipidMax selectively ... yield in plants, possessing a wide variety of ...
Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3
... Gen-Probe Incorporated (NASDAQ: GPRO ) today ... revenues in the quarter grew 16%, to a new record ... 18%, to a new high of $0.72. "Gen-Probe ... fourth quarter while clinical diagnostics revenues continued their solid growth," ...
... Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer ... prescription medications, announced today that the company plans to ... beginning of the forthcoming month of March 2012 ... 1 Technologies is authorized to repurchase up to 10 ...
... New York, February 14, 2012 ... Oxygen Concentrator Market Shares, Strategies, and Forecasts, Worldwide, 2012 ... that it has a new study on Oxygen Concentrator ... has 524 pages, 191 tables and figures. , ,Reimbursement ...
Cached Biology Technology:Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 2Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 3Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 4Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 5Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 6Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 7Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 8Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 9Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 10Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 11Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 12Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 13Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 14Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 15Medisafe 1 Technologies to Start the $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share 2ResearchMoz: Oxygen Concentrator Market Shares, Strategies and Forecasts, Worldwide, 2012 to 2018 2ResearchMoz: Oxygen Concentrator Market Shares, Strategies and Forecasts, Worldwide, 2012 to 2018 3ResearchMoz: Oxygen Concentrator Market Shares, Strategies and Forecasts, Worldwide, 2012 to 2018 4ResearchMoz: Oxygen Concentrator Market Shares, Strategies and Forecasts, Worldwide, 2012 to 2018 5
(Date:5/23/2013)... the world,s most popular fruit, can be made both ... GM varieties. , "Working with GM tomatoes that ... of a specific compound, allows us to pinpoint exactly ... Martin from the John Innes Centre. , The research ... health and shelf life characteristics because even higher levels ...
(Date:5/23/2013)... than 13,000 ships per year, carrying more than 284 million ... roughly $1.8 billion dollars in toll fees for the Panama ... 55 million gallons of water are used from Gatun Lake, ... million people living in the isthmus. , However, the ... 20 percent of the ships at sea, has demanded change. ...
(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
... forest products industry has been growing rapidly since ... U.S. economy annually. Examples of nontimber forest products ... medicinal and herbal products, and specialty floral and ... U.S.-grown herbs used to satisfy increasing consumer demand ...
... with her studies challenging a popular theory that an ... evidence asserting her position. Gerta Keller, whose studies ... States, Mexico and India have led her to conclude ... likely culprits in the demise of the Earth,s giant ...
... & Life Sciences Division (DBIO) of the Special Libraries ... of biology and medicine over the last 100 years ... among them. In the poll, 686 DBIO members ... "Journals of Land Invertebrates" category. Annals celebrated its 100th ...
Cached Biology News:Decreasing deer damage 2Decreasing deer damage 3Princeton geoscientist offers new evidence that meteorite did not wipe out dinosaurs 2Princeton geoscientist offers new evidence that meteorite did not wipe out dinosaurs 3Princeton geoscientist offers new evidence that meteorite did not wipe out dinosaurs 4'Annals of the ESA' selected as one of 100 most influential journals 2
... bioassays for interferons are cytopathic effect inhibition assays, ... Sample types include; tissue culture supernatents; serum from ... assays, one unit is defined as the quantity ... cytopathic effect of viral infection by 50%. ...
HyPro 100, includes 5 x HyPro20 and HyPro Cabinet. 100 slide capacity. Active vibration system, slide rack and humidity chamber. Ideal for microarray and in situ hybridization....
... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...
Request Info...
Biology Products: